Humana management commentary attributes Q3 2026 adjusted earnings outperformance to strong Insurance segment results

• Humana management commentary reported a third-quarter 2026 adjusted loss of $0.70 per share, better than the approximately $1 loss expected.
• Insurance results drove the outperformance, with a 93.7% benefit ratio; medical and pharmacy cost trends were in line with or better than expectations.
• Membership growth, operating leverage and cost reductions lowered the year-to-date adjusted consolidated operating cost ratio 80 basis points to 10.3%.
• Individual Medicare Advantage membership rose approximately 1,208,000 year to date, or 23%, tracking in line with expectations.
• CenterWell Pharmacy revenue grew 18% year to date, driven by membership growth, mail-order penetration and expansion beyond Humana’s membership.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humana Inc. published the original content used to generate this news brief on November 06, 2026, and is solely responsible for the information contained therein.